- Report
- March 2025
- 193 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- February 2025
- 183 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- October 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- January 2025
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- July 2024
- 144 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- March 2025
- 255 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 89 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 92 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 93 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 162 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- March 2025
- 309 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- February 2025
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- September 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 175 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP

The Cancer Research market is a subset of the Drug Discovery market, focused on the development of treatments for cancer. This market is composed of a variety of stakeholders, including pharmaceutical companies, research institutions, and government agencies. These stakeholders collaborate to develop new treatments and therapies for cancer, as well as to improve existing treatments. The market is driven by the need to find new and effective treatments for cancer, as well as to improve the quality of life for those affected by the disease.
The Cancer Research market is highly competitive, with many companies vying for a share of the market. Companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. These companies are engaged in research and development of new treatments and therapies for cancer, as well as the marketing and distribution of existing treatments. Show Less Read more